ZIM Laboratories Ltd

Stage 2 · Advancing · week 27Setup 7.9 ★★ GoodEven −0.7

As of 20 Nov 2026, ZIM Laboratories is in Stage 2, the uptrend phase, now in week 27 (since 13 May 2026). It closed at ₹148, 3.2% below its 52-week high and above its 200-day average, which is rising. In Health Care, 34.7% of stocks are in Stage 2.

ZIM Laboratories Limited engages in the development, manufacture, and supply of generic pharmaceutical and nutraceutical products in India and internationally. More about the company

₹147.8
Close, 20 Nov 2026
-0.69% on the day
₹793 Cr · Small cap
Market DowntrendHealth Care 34.7% in Stage 2-11.4 pts / 20dPharmaceuticals 42.4%-13.9 pts

Pro read

Pro

Our read

Well into a healthy advance

Setup score

7.9 ★★ Good

RS rank

Edge

Even −0.7

ZIMLAB is about 6 months into its Stage 2 advance, 7% above its 50-day average and 3% under its 52-week high. Moves this far along have tended to keep doing well for as long as the trend stays intact.

Its relative strength is 96 of 99, a leader among NSE stocks over the past year. Pharmaceuticals ranks 7 of 106 industries by the strength of its stocks, among the leaders.

Stocks with a similar setup at this point in their move ran 0.7 points behind the average stock over the next 30 sessions on average, after costs, and their typical best close within 60 sessions was 17% above entry.

The trend read holds while it stays in Stage 2. A close below ₹138, its 50-day average, would put it at rest; ₹122, 20% under its 52-week high of ₹153, is where a trailing stop would sit.

Setup-score rank among Stage 2 peers: #26 of 50 in Pharmaceuticals · #33 of 61 in Health Care

Is ZIMLAB early, or has it already run? Pro answers that for every NSE stock, after every close.

Loading price chart…
Stage Cycle Timeline2023-08-24 → 2026-11-20
S3 16w
S4 19w
S4 20w
S2 27w
2023-08-242026-11-20
S1S2S3S4Setup score (0–10, dashed line at 5)
S? 3w → S2 5w → S3 16w → S4 13w → S1 10w → S4 3w → S1 2w → S2 6w → S3 6w → S4 2w → S3 2w → S2 4w → S4 19w → S1 6w → S2 5w → S3 2w → S4 20w → S1 7w → S4 7w → S1 2w → S2 27w current
Total tracked: 168 weeks across 21 stage runs.

ZIMLAB among Pharmaceuticals11th of 118 by relative strength

All 118 →
Stocks in Pharmaceuticals ranked by relative strength, with stage and one-month change
#StockStageRS1M
1BLISSGVSStage 2 · wk 4999+4.6%
2KPLStage 2 · wk 4499+20.5%
3FREDUNStage 2 · wk 3398+24.0%
4VENUSREMStage 3 · wk 1098−1.5%
5RUBICONStage 3 · wk 498+18.7%
6SAKARStage 2 · wk 5598+13.1%
7BAFNAPHStage 2 · wk 2398+1.9%
8INDSWFTLABStage 2 · wk 2398−7.4%
…11ZIMLABStage 2 · wk 2796+11.7%
vs 52W High
-3.2%
₹60.3 lo₹152.6 hi
3.2% below 52W high, pullback range
How far this stock is from its 52-week high. A stock a little below its high with its Stage 2 structure intact is in a pullback, not a breakdown.
Stage Maturity
Week 27
1w13w26w
Week 27, mature
How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.
vs 200 DMA
38.2%
200 DMA: ₹107 · rising
The stock is above its 200-day average, the long-term trend line. That is where a Stage 2 advance normally trades.
Rel Volume
0.81x
vs 50-day avg
Volume was close to average, nothing unusual. In a Stage 2 advance, look for heavy volume on breakouts and quiet volume on pullbacks.
Trend Health
↓
Short-term trend rolling over
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
+11.7%
3M
+25.2%
6M
+49.1%
YTD
+104.9%
1Y
+101.2%
Sector
Health Care
↓ Peaking
Stage 2%
34.7%
20d Δ
-11.4pp
1M return
+11.5%
3M return
+3.8%
Sector Stage-2 % · last 20 days
This stock ranks #9 of 58 Stage 2 stocks in Health Care by RS. Leading the sector.
Industry
Pharmaceuticals
↓ Peaking
Stage 2%
42.4%
20d Δ
-13.9pp
1M return
+8.3%
3M return
+2.1%
Industry Stage-2 % · last 20 days
Ranks #8 of 48 Stage 2 stocks in this industry. Top tier.

Mutual fund holdings

Held by 1 mutual funds in portfolios to October 2026: 1 active funds and 0 index funds and ETFs.

In October, no active fund changed its holding.

Largest active holders, by weight in the fund
All 1 funds and what each did in October

Mutual funds holding ZIMLAB: the ten largest and the month’s moves →

Fund details on DiscoverMF

Scan Membership
Not in any scan now.
Last appeared 12 Nov 2026
Last appeared 8 Sep 2026
Last appeared 13 May 2026
31 appearances in the last 60 days.
Recent Stage Timeline
2026-11-20S2
Wk 27 · Vol 0.81x
2026-11-19S2
Wk 27 · Vol 11.07x
2026-11-18S2
Wk 26 · Vol 0.09x
2026-11-17S2
Wk 26 · Vol 0.25x
2026-11-16S2
Wk 26 · Vol 0.17x
2026-11-13S2
Wk 26 · Vol 0.41x
2026-11-12S2
Wk 26 · Vol 0.70x
2026-11-11S2
Wk 25 · Vol 0.17x
2026-11-09S2
Wk 25 · Vol 0.30x
2026-11-06S2
Wk 25 · Vol 0.35x
2026-11-05S2
Wk 25 · Vol 1.53x
2026-11-04S2
Wk 25 · Vol 0.78x
Moving averages & range
50 DMA
₹137.9
200 DMA
₹107
52W High
₹152.6
52W Low
₹60.3
5D Low
₹135.5
Resistance levels (recent highs)
20d High
₹148.8
60d High
₹152.6
120d High
₹152.6
250d High
₹152.6
Next resistance
+0.7%
to 20d High
P/E (TTM)
171.8
Forward —
Earnings Growth (YoY)
+20.8%
Revenue +18.9%
ROE
+0.8%
Profit margin +0.5%
Dividend Yield
0.00%
P/B 2.6

ZIM Laboratories: quick answers

What stage is ZIM Laboratories in?

As of 20 Nov 2026, ZIM Laboratories (ZIMLAB) is in Stage 2, the uptrend phase. It entered Stage 2 on 13 May 2026 and is in week 27. What the four stages mean

Is ZIM Laboratories in an uptrend?

Yes. ZIM Laboratories is in a Stage 2 uptrend. It trades 38.2% above its 200-day average, which is rising.

How far is ZIM Laboratories from its 52-week high?

ZIM Laboratories closed at ₹148 on 20 Nov 2026, 3.2% below its 52-week high of ₹153. Its 52-week low is ₹60.26.

How has ZIM Laboratories performed over the past year?

As of 20 Nov 2026, ZIM Laboratories is up 101.2% over the past year and up 104.9% so far in 2026.

Which sector and industry is ZIM Laboratories in?

ZIM Laboratories is in the Pharmaceuticals industry, part of the Health Care sector. 61 stocks in Health Care are in Stage 2, 34.7% of the sector. See the Stage 2 stocks in Pharmaceuticals

About this companyHealth Care· Pharmaceuticals

ZIM Laboratories Limited engages in the development, manufacture, and supply of generic pharmaceutical and nutraceutical products in India and internationally. It provides its products in pre- formulation intermediates and finished formulations in the oral solid dosage forms, such as pellets, taste-masked powders, granules, tablets, capsules, dry syrup, and oral thin films. The company offers therapeutics in the areas of urology, gastroenterology, antibiotics, anti-infectives, cardiovascular, central nervous system, NSAIDs/pain analgesics, and vitamins and supplements. The company was incorporated in 1984 and is based in Nagpur, India.

Visit company website →

All analytics based on EOD data. Data as of 2026-11-20. Past data patterns are not indicative of future results. This page is a data analytics tool only.